Breast cancer study explores therapy to slow recurrence. Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment.
A device co-developed by a University of Houston physicist to detect the spread of breast cancer and allow physicians to better plan intervention is extending its market reach, bringing it another step closer to clinical trials in the United States.
Advocacy In Action: Where To Get Molecular Tumor Testing?
Southern California, Breast Cancer, Programming, Medical
Eight stellar breast cancer investigators present cases and talk about related trials and data